title: A chemical approach for identifying O-GlcNAc-modified proteins in cells.
abstract: The glycosylation of serine and threonine residues with a single GlcNAc moiety is a dynamic posttranslational modification of many nuclear and cytoplasmic proteins. We describe a chemical strategy directed toward identifying O-GlcNAc-modified proteins from living cells or proteins modified in vitro. We demonstrate, in vitro, that each enzyme in the hexosamine salvage pathway, and the enzymes that affect this dynamic modification (UDP-GlcNAc:polypeptidtyltransferase and O-GlcNAcase), tolerate analogues of their natural substrates in which the N-acyl side chain has been modified to bear a bio-orthogonal azide moiety. Accordingly, treatment of cells with N-azidoacetylglucosamine results in the metabolic incorporation of the azido sugar into nuclear and cytoplasmic proteins. These O-azidoacetylglucosamine-modified proteins can be covalently derivatized with various biochemical probes at the site of protein glycosylation by using the Staudinger ligation. The approach was validated by metabolic labeling of nuclear pore protein p62, which is known to be posttranslationally modified with O-GlcNAc. This strategy will prove useful for both the identification of O-GlcNAc-modified proteins and the elucidation of the specific residues that bear this saccharide.
authors.affiliation: Center for New Directions in Organic Synthesis, Department of Chemistry, University of California, Berkeley, CA 94720, USA.
authors.forename: David J
authors.initials: DJ
authors.lastname: Vocadlo
authors.forename: Howard C
authors.initials: HC
authors.lastname: Hang
authors.forename: Eun-Ju
authors.initials: EJ
authors.lastname: Kim
authors.forename: John A
authors.initials: JA
authors.lastname: Hanover
authors.forename: Carolyn R
authors.initials: CR
authors.lastname: Bertozzi
mesh_terms: D000117:Acetylglucosamine / Q000378:metabolism*; D015153:Blotting, Western; D002467:Cell Nucleus / Q000378:metabolism; D003001:Cloning, Molecular; D003593:Cytoplasm / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D006031:Glycosylation; D006595:Hexosamines / Q000737:chemistry; D006801:Humans; D019169:Jurkat Cells; D007700:Kinetics; D008956:Models, Chemical; D022022:Nuclear Pore / Q000378:metabolism; D017875:Phosphotransferases (Phosphomutases) / Q000235:genetics / Q000378:metabolism; D011233:Precipitin Tests; D011499:Protein Processing, Post-Translational; D011506:Proteins / Q000378:metabolism*; D011994:Recombinant Proteins / Q000378:metabolism; D012694:Serine / Q000378:metabolism; D013379:Substrate Specificity; D013912:Threonine / Q000378:metabolism; D014407:Tumor Cells, Cultured
chemical_list: D006595:Hexosamines; D011506:Proteins; D011994:Recombinant Proteins; D013912:Threonine; D012694:Serine; D017875:Phosphotransferases (Phosphomutases); C018718:phosphoacetylglucosamine mutase; D000117:Acetylglucosamine